Stock data

向榮生技 (6794)

向榮生技 is a TWSE-listed company in Biotech & Medical Care. Revenue for September 2026 was NT$2.50M, up 83.7% from a year earlier. EPS over the last four quarters totals -NT$1.65.

Charts, drawing tools, and the P/E calculator are in the app, free to use.

Open 向榮生技 in Insightr